Cargando…

Hypouricemia and Urate Transporters

Hypouricemia is recognized as a rare disorder, defined as a serum uric acid level of 2.0 mg/dL or less. Hypouricemia is divided into an overexcretion type and an underproduction type. The former typical disease is xanthinuria, and the latter is renal hypouricemia (RHUC). The frequency of nephrogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Otani, Naoyuki, Ouchi, Motoshi, Misawa, Kazuharu, Hisatome, Ichiro, Anzai, Naohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945357/
https://www.ncbi.nlm.nih.gov/pubmed/35327453
http://dx.doi.org/10.3390/biomedicines10030652
_version_ 1784673939465699328
author Otani, Naoyuki
Ouchi, Motoshi
Misawa, Kazuharu
Hisatome, Ichiro
Anzai, Naohiko
author_facet Otani, Naoyuki
Ouchi, Motoshi
Misawa, Kazuharu
Hisatome, Ichiro
Anzai, Naohiko
author_sort Otani, Naoyuki
collection PubMed
description Hypouricemia is recognized as a rare disorder, defined as a serum uric acid level of 2.0 mg/dL or less. Hypouricemia is divided into an overexcretion type and an underproduction type. The former typical disease is xanthinuria, and the latter is renal hypouricemia (RHUC). The frequency of nephrogenic hypouricemia due to a deficiency of URAT1 is high in Japan, accounting for most asymptomatic and persistent cases of hypouricemia. RHUC results in a high risk of exercise-induced acute kidney injury and urolithiasis. It is vital to promote research on RHUC, as this will lead not only to the elucidation of its pathophysiology but also to the development of new treatments for gout and hyperuricemia.
format Online
Article
Text
id pubmed-8945357
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89453572022-03-25 Hypouricemia and Urate Transporters Otani, Naoyuki Ouchi, Motoshi Misawa, Kazuharu Hisatome, Ichiro Anzai, Naohiko Biomedicines Review Hypouricemia is recognized as a rare disorder, defined as a serum uric acid level of 2.0 mg/dL or less. Hypouricemia is divided into an overexcretion type and an underproduction type. The former typical disease is xanthinuria, and the latter is renal hypouricemia (RHUC). The frequency of nephrogenic hypouricemia due to a deficiency of URAT1 is high in Japan, accounting for most asymptomatic and persistent cases of hypouricemia. RHUC results in a high risk of exercise-induced acute kidney injury and urolithiasis. It is vital to promote research on RHUC, as this will lead not only to the elucidation of its pathophysiology but also to the development of new treatments for gout and hyperuricemia. MDPI 2022-03-11 /pmc/articles/PMC8945357/ /pubmed/35327453 http://dx.doi.org/10.3390/biomedicines10030652 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Otani, Naoyuki
Ouchi, Motoshi
Misawa, Kazuharu
Hisatome, Ichiro
Anzai, Naohiko
Hypouricemia and Urate Transporters
title Hypouricemia and Urate Transporters
title_full Hypouricemia and Urate Transporters
title_fullStr Hypouricemia and Urate Transporters
title_full_unstemmed Hypouricemia and Urate Transporters
title_short Hypouricemia and Urate Transporters
title_sort hypouricemia and urate transporters
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945357/
https://www.ncbi.nlm.nih.gov/pubmed/35327453
http://dx.doi.org/10.3390/biomedicines10030652
work_keys_str_mv AT otaninaoyuki hypouricemiaanduratetransporters
AT ouchimotoshi hypouricemiaanduratetransporters
AT misawakazuharu hypouricemiaanduratetransporters
AT hisatomeichiro hypouricemiaanduratetransporters
AT anzainaohiko hypouricemiaanduratetransporters